Nipro Corporation, founded in 1954 and headquartered in Osaka, Japan, is a global leader in the manufacturing and distribution of medical devices and pharmaceutical packaging. The company specializes in developing innovative solutions, including dialysis equipment, intravenous (IV) devices, and various types of packaging for pharmaceuticals.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| NISSHO 1.60% 2055-09-28 JPYNipro Corporation | Japan | 2055-09-28 | 1.600 | 4.93 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Nipro Corporation began issuing bonds in the late 1990s to support its expansion efforts and R&D initiatives. Notably, its 2020 bond issuance raised substantial capital aimed at enhancing production capabilities and entering new markets. As of now, Nipro's bonds offer competitive yields compared to industry benchmarks, reflecting solid credit ratings and investor confidence. Recent reports indicate that the company is considering additional issuances to fund new technology investments and strategic acquisitions.